These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7248140)

  • 1. The pharmacokinetics of nortriptyline in patients with chronic renal failure.
    Dawlilng S; Lynn K; Rosser R; Braithwaite R
    Br J Clin Pharmacol; 1981 Jul; 12(1):39-45. PubMed ID: 7248140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nortriptyline metabolism in chronic renal failure: metabolite elimination.
    Dawling S; Lynn K; Rosser R; Braithwaite R
    Clin Pharmacol Ther; 1982 Sep; 32(3):322-9. PubMed ID: 7105623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers.
    Dawling S; Crome P; Braithwaite R
    Clin Pharmacokinet; 1980; 5(4):394-401. PubMed ID: 6994983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nortriptyline capacity-limited metabolism: a case report.
    Browne JL; Perry PJ; Taylor JW; Sieleni BA; Kronfol Z
    J Clin Psychopharmacol; 1984 Dec; 4(6):322-5. PubMed ID: 6511999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nortriptyline pharmacokinetic parameters in depressed children and adolescents: preliminary data.
    Geller B; Cooper TB; Chestnut E; Abel AS; Anker JA
    J Clin Psychopharmacol; 1984 Oct; 4(5):265-9. PubMed ID: 6490962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.
    Flouvat BL; Imbert C; Dubois DM; Temperville BP; Roux AF; Chevalier GC; Humbert G
    Br J Clin Pharmacol; 1983 Jun; 15(6):735-41. PubMed ID: 6871072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-pass metabolism of nortriptyline in man.
    Gram LF; Overo KF
    Clin Pharmacol Ther; 1975 Sep; 18(3):305-14. PubMed ID: 1164819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole.
    Toon S; Ross CE; Gokal R; Rowland M
    Br J Clin Pharmacol; 1990 Feb; 29(2):221-6. PubMed ID: 2306414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of single doses of metoclopramide in renal failure.
    Bateman DN; Gokal R; Dodd TR; Blain PG
    Eur J Clin Pharmacol; 1981; 19(6):437-41. PubMed ID: 7250177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.
    Flouvat B; Decourt S; Aubert P; Potaux L; Domart M; Goupil A; Baglin A
    Br J Clin Pharmacol; 1980 Apr; 9(4):379-85. PubMed ID: 7378254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nortriptyline kinetics in Hispanic and Anglo subjects.
    Gaviria M; Gil AA; Javaid JI
    J Clin Psychopharmacol; 1986 Aug; 6(4):227-31. PubMed ID: 3734142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
    Puttonen J; Kantele S; Kivikko M; Häkkinen S; Harjola VP; Koskinen P; Pentikäinen PJ
    Clin Pharmacokinet; 2007; 46(3):235-46. PubMed ID: 17328582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis.
    Riva E; Fossali E; Bettinelli A
    Eur J Clin Pharmacol; 1982; 21(4):303-6. PubMed ID: 7056274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.
    Rubin EH; Biggs JT; Preskorn SH
    J Clin Psychiatry; 1985 Oct; 46(10):418-24. PubMed ID: 3900052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinidazole pharmacokinetics in severe renal failure.
    Robson RA; Bailey RR; Sharman JR
    Clin Pharmacokinet; 1984; 9(1):88-94. PubMed ID: 6692632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.
    Gram LF; Andreasen PB; Overo KF; Christiansen J
    Psychopharmacology (Berl); 1976 Oct; 50(1):21-7. PubMed ID: 827758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of nomifensine in impaired renal function.
    Ringoir S; Lameire N; Munche M; Heptner W; Taeuber K
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):129S-134S. PubMed ID: 334214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose kinetics and dosage of mecillinam in renal failure and haemodialysis.
    Schapira A
    Clin Pharmacokinet; 1984; 9(4):364-70. PubMed ID: 6088153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.